Translational research and the U.S. federal elections

Sci Transl Med. 2016 Oct 19;8(361):361ed13. doi: 10.1126/scitranslmed.aah5233.

Authors

Jonathan Kimmelman^{1

2}, Aaron S Kesselheim^{1

2}

Affiliations

¹ Jonathan Kimmelman, Studies of Translation, Ethics and Medicine (STREAM), Biomedical Ethics Unit, McGill University, Montréal, Québec H3A 1X1, Canada. Email: jonathan.kimmelman@mcgill.ca.
² Aaron S. Kesselheim, Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham Women's Hospital, Harvard Medical School, Boston, MA 02120, USA.

PMID: 27798261
DOI: 10.1126/scitranslmed.aah5233

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Federal Government
Politics
Translational Research, Biomedical / legislation & jurisprudence*
United States